Fighting skin cancer with a Patient's own supercharged immune cells
NCT ID NCT07288203
Summary
This study is testing a personalized cell therapy called lifileucel for people with advanced melanoma that has worsened after standard immunotherapy. Doctors take immune cells from a patient's tumor, grow large numbers of them in a lab, and infuse them back into the patient to attack the cancer. The trial aims to see if this approach can shrink tumors and control the disease in 100 participants who have limited treatment options.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UNRESECTABLE MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre Hospitalier de l'Universite de Montreal
RECRUITINGMontral, Quebec, Canada, H2X 0A9, Canada
-
Greenslopes Private Hospital
RECRUITINGGreenslopes, Queensland, 4120, Australia
-
Princess Margaret Cancer Centre
RECRUITINGToronto, Ontario, Canada, M5G 2M9, Canada
-
Royal Marsden Hospital
RECRUITINGLondon, SW3 6JJ, United Kingdom
-
Sarah Cannon Research Institute
RECRUITINGNashville, Tennessee, 37203, United States
Conditions
Explore the condition pages connected to this study.